These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29430847)

  • 1. Dual Labeling of the CBP/p300 KIX Domain for
    Gee CT; Arntson KE; Koleski EJ; Staebell RL; Pomerantz WCK
    Chembiochem; 2018 May; 19(9):963-969. PubMed ID: 29430847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragment screening and druggability assessment for the CBP/p300 KIX domain through protein-observed 19F NMR spectroscopy.
    Gee CT; Koleski EJ; Pomerantz WC
    Angew Chem Int Ed Engl; 2015 Mar; 54(12):3735-9. PubMed ID: 25651535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP.
    Lee CW; Arai M; Martinez-Yamout MA; Dyson HJ; Wright PE
    Biochemistry; 2009 Mar; 48(10):2115-24. PubMed ID: 19220000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural and mechanistic insights into the interaction of the circadian transcription factor BMAL1 with the KIX domain of the CREB-binding protein.
    Garg A; Orru R; Ye W; Distler U; Chojnacki JE; Köhn M; Tenzer S; Sönnichsen C; Wolf E
    J Biol Chem; 2019 Nov; 294(45):16604-16619. PubMed ID: 31515273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NMR mapping of the HIV-1 Tat interaction surface of the KIX domain of the human coactivator CBP.
    Vendel AC; Lumb KJ
    Biochemistry; 2004 Feb; 43(4):904-8. PubMed ID: 14744133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structurally distinct modes of recognition of the KIX domain of CBP by Jun and CREB.
    Campbell KM; Lumb KJ
    Biochemistry; 2002 Nov; 41(47):13956-64. PubMed ID: 12437352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SAR by (Protein-Observed)
    Divakaran A; Kirberger SE; Pomerantz WCK
    Acc Chem Res; 2019 Dec; 52(12):3407-3418. PubMed ID: 31718149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring CREB activation using bioluminescent probes that detect KID-KIX interaction in living cells.
    Ishimoto T; Mano H; Ozawa T; Mori H
    Bioconjug Chem; 2012 May; 23(5):923-32. PubMed ID: 22506514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of small-molecule antagonists that inhibit an activator: coactivator interaction.
    Best JL; Amezcua CA; Mayr B; Flechner L; Murawsky CM; Emerson B; Zor T; Gardner KH; Montminy M
    Proc Natl Acad Sci U S A; 2004 Dec; 101(51):17622-7. PubMed ID: 15585582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular characterization of HTLV-1 Tax interaction with the KIX domain of CBP/p300.
    Ramírez JA; Nyborg JK
    J Mol Biol; 2007 Sep; 372(4):958-969. PubMed ID: 17707401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural analyses of CREB-CBP transcriptional activator-coactivator complexes by NMR spectroscopy: implications for mapping the boundaries of structural domains.
    Radhakrishnan I; Pérez-Alvarado GC; Parker D; Dyson HJ; Montminy MR; Wright PE
    J Mol Biol; 1999 Apr; 287(5):859-65. PubMed ID: 10222196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent Chemical Cochaperones of the p300/CBP GACKIX Domain.
    Lodge JM; Majmudar CY; Clayton J; Mapp AK
    Chembiochem; 2018 Sep; 19(18):1907-1912. PubMed ID: 29939485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling the dynamic interfaces of fluorinated transcription complexes for ligand discovery and characterization.
    Pomerantz WC; Wang N; Lipinski AK; Wang R; Cierpicki T; Mapp AK
    ACS Chem Biol; 2012 Aug; 7(8):1345-50. PubMed ID: 22725662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnitude of the CREB-dependent transcriptional response is determined by the strength of the interaction between the kinase-inducible domain of CREB and the KIX domain of CREB-binding protein.
    Shaywitz AJ; Dove SL; Kornhauser JM; Hochschild A; Greenberg ME
    Mol Cell Biol; 2000 Dec; 20(24):9409-22. PubMed ID: 11094091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current development of CBP/p300 inhibitors in the last decade.
    He ZX; Wei BF; Zhang X; Gong YP; Ma LY; Zhao W
    Eur J Med Chem; 2021 Jan; 209():112861. PubMed ID: 33045661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leu628 of the KIX domain of CBP is a key residue for the interaction with the MLL transactivation domain.
    Arai M; Dyson HJ; Wright PE
    FEBS Lett; 2010 Nov; 584(22):4500-4. PubMed ID: 20969867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel p300-specific-associating protein, PRS1 (phosphoribosylpyrophosphate synthetase subunit 1).
    Kaida A; Ariumi Y; Baba K; Matsubae M; Takao T; Shimotohno K
    Biochem J; 2005 Oct; 391(Pt 2):239-47. PubMed ID: 15943588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures of KIX domain of CBP in complex with two FOXO3a transactivation domains reveal promiscuity and plasticity in coactivator recruitment.
    Wang F; Marshall CB; Yamamoto K; Li GY; Gasmi-Seabrook GM; Okada H; Mak TW; Ikura M
    Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6078-83. PubMed ID: 22474372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human T-cell leukemia virus type 1 tax protein confers CBP/p300 recruitment and transcriptional activation properties to phosphorylated CREB.
    Geiger TR; Sharma N; Kim YM; Nyborg JK
    Mol Cell Biol; 2008 Feb; 28(4):1383-92. PubMed ID: 18070920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Based Identification of Inhibitory Fragments Targeting the p300/CBP-Associated Factor Bromodomain.
    Chaikuad A; Lang S; Brennan PE; Temperini C; Fedorov O; Hollander J; Nachane R; Abell C; Müller S; Siegal G; Knapp S
    J Med Chem; 2016 Feb; 59(4):1648-53. PubMed ID: 26731131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.